140 related articles for article (PubMed ID: 26425439)
1. Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction.
Zhang X; Zhang X; Lei M; Lin Y; Megson IL; Wei J; Yu B; Jin Y
FEBS Open Bio; 2015; 5():712-6. PubMed ID: 26425439
[TBL] [Abstract][Full Text] [Related]
2. Associations between circulating IgG antibodies to Apolipoprotein B
Hu W; Zhang X; Han Y; Wang Y; Lei M; Megson IL; Wei J; Jin Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30242056
[No Abstract] [Full Text] [Related]
3. A study of IgG antibodies to the ApoB protein in non-ST segment elevation acute coronary syndrome.
Zhang X; Yu B; Jin Y; Lei M; Zhang X; Duan Z; Lin Y; Megson IL; Wei J
Scand Cardiovasc J; 2015 Jun; 49(3):136-41. PubMed ID: 25833671
[TBL] [Abstract][Full Text] [Related]
4. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez M; Ferrer-Hita J; Vargas M; Reiter RJ
Atherosclerosis; 2005 May; 180(1):101-5. PubMed ID: 15823281
[TBL] [Abstract][Full Text] [Related]
6. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
7. High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.
Engelbertsen D; Anand DV; Fredrikson GN; Hopkins D; Corder R; Shah PK; Lahiri A; Nilsson J; Bengtsson E
J Intern Med; 2012 Jan; 271(1):82-9. PubMed ID: 21668821
[TBL] [Abstract][Full Text] [Related]
8. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
9. Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation.
van der Zwan LP; Teerlink T; Dekker JM; Henry RM; Stehouwer CD; Jakobs C; Heine RJ; Scheffer PG
J Lipid Res; 2009 Feb; 50(2):342-9. PubMed ID: 18802196
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
Vuilleumier N; Bratt J; Alizadeh R; Jogestrand T; Hafström I; Frostegård J
Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
[TBL] [Abstract][Full Text] [Related]
11. Locally produced anti-phosphorylcholine and anti-oxidized low-density lipoprotein antibodies in gingival crevicular fluid from aggressive periodontitis patients.
Schenkein HA; Berry CR; Burmeister JA; Brooks CN; Best AM; Tew JG
J Periodontol; 2004 Jan; 75(1):146-53. PubMed ID: 15025226
[TBL] [Abstract][Full Text] [Related]
12. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis.
Hermansson A; Ketelhuth DF; Strodthoff D; Wurm M; Hansson EM; Nicoletti A; Paulsson-Berne G; Hansson GK
J Exp Med; 2010 May; 207(5):1081-93. PubMed ID: 20439543
[TBL] [Abstract][Full Text] [Related]
15. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
Trpkovic A; Resanovic I; Stanimirovic J; Radak D; Mousa SA; Cenic-Milosevic D; Jevremovic D; Isenovic ER
Crit Rev Clin Lab Sci; 2015; 52(2):70-85. PubMed ID: 25537066
[TBL] [Abstract][Full Text] [Related]
16. [The characteristics of high density lipoprotein cholesterol and the relationship between high density lipoprotein cholesterol and the severity of coronary artery lesions in young men with acute myocardial infarction].
Li Z; Tao Y; Huang J; Wang Q; Zhang DH; Wu XY
Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1458-62. PubMed ID: 24029567
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Matsuura E; Kobayashi K; Hurley BL; Lopez LR
Lupus; 2006; 15(7):478-83. PubMed ID: 16898186
[TBL] [Abstract][Full Text] [Related]
18. Study of circulating IgG antibodies to BIRC5 and MYC in non-small cell lung cancer.
Ye L; Wang W; Chen C; Meng Q; Yu Y
FEBS Open Bio; 2015; 5():809-12. PubMed ID: 26566475
[TBL] [Abstract][Full Text] [Related]
19. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
[TBL] [Abstract][Full Text] [Related]
20. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
